The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3- benzodioxane) in adjuvant-induced arthritis (AIA) in rats

Inflammation Research

Volumn 61, Issue 8, 2012, Pages 875-887

  Shah, Syed Uzair Ali ^a   Ashraf, Nadeem ^a   Soomro, Zahid H ^a   Shah, Muhammad Raza ^a   Kabir, Nurul ^a   Simjee, Shabana Usman ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

6 Nitro 1,3 Benzodioxane; Adjuvant induced arthritis; Interleukin 1 ; Reactive oxygen species; Tumor necrosis factor

Indexed keywords

6 NITRO 1,3 BENZODIOXANE; ANTIRHEUMATIC AGENT; BACTERIUM LYSATE; GLUTATHIONE; INDOMETACIN; INTERLEUKIN 1BETA; NITRIC OXIDE; PEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIC SCORE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG STRUCTURE; FEMALE; GLUTATHIONE SERUM; HARGREAVE METHOD; HIND PAW INFLAMMATION; HISTOLOGY; HYPERALGESIA; INJURY SCALE; MEDICAL PARAMETERS; NITRIC OXIDE SERUM; NONHUMAN; PAIN PARAMETERS; PAIN THRESHOLD; PAW EDEMA; PAW VOLUME MEASUREMENT; PEROXIDE SERUM; PROTEIN BLOOD LEVEL; RAT; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DIOXANES; FEMALE; GLUTATHIONE; HYPERALGESIA; INTERLEUKIN-1BETA; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; PEROXIDES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865137699     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0480-4     Document Type: Article

References (88)

1. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Ruddy S, Harris JED, Sledge CB, Budd RC, Sergent JS, editors. Kelley's text book of rheumatology, vol. 2. Philadelphia: Saunders; 2001. p. 921-6.
2. Verbnrgge LM, Patrick DL. Seven chronic conditions: their impact on US adults' activity levels and use of medical Services. Am J Public Health. 1995;85:173-82.
3. Lard LR, Huizinga TWJ, Hazes JMW, Vliet Vlieland TPM. Delayed referral of female rheumatoid arthritis patients. J Rheumatol. 2001; 28:2190-2. (Pubitemid 32947860)
4. CDC. Prevalence of doctor-diagnosed arthritis and arthritisattributable activity limitation-United States, 2007-2009. MMWR. 2010; 59:1261-5.
5. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307.
6. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-4.
7. Brinckerhoff CE, Sporn MB. Retinoids and rexinoids for the 21st century. J Rheumatol. 2003; 30:211-13.
8. Kaplan JC, Valdez R, Chandrasekaran H, Eibel K, Mikecz TT. Glant and A. Finnegan, Th1 and Th2 cytokines regulate proteoglycan- specific autoantibody isotypes and arthritis. Arthritis Res. 2002;4:545-58.
9. Maini RN, Taylor PC. Anti-cytokines therapy for rheumatoid arthritis. Annu Rev Med. 2000;51:207-29.
10. Van den berg WB. Anti-cytokine therapy in chronic destructive arthritis. J Arthritis Res. 2001; 3:18-26.
11. Goronzy JJ, Weyand CM. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol. 2001;22: 251-5. (Pubitemid 32667512)
12. Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N. Enrichment of differentiated CD45RBdim, CD27 memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:844-54.
13. Falgarone G, Semerano L, Rullé S, Boissier MC. Targeting lymphocyte activation to treat rheumatoid arthritis. Joint Bone Spine. 2009;76:327-32.
14. Abreu JR, Grabiec AM, Krausz S, Spijker R, Burakowski T, Maslinski W, et al. The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling. J Immunol. 2009;183:621-30.
15. Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, et al. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 2009;60:966-75.
16. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 1992;35:729-35.
17. Szekanecz Z, Koch AE, Kunkel SL, Strieter RM. Cytokines in rheumatoid arthritis: potential targets for pharmacological intervention. Drugs Aging. 1998;12:377-90. (Pubitemid 28220849)
18. Gravallese EM, Goldring SR. Cellular mechanism and the role of cytokines in erosions in rheumatoid arthritis. Arthritis Rheum. 2000;43:2143-51.
19. Fan AY, Lao L, Zhang RX, Zhou AN, Wang LB, Moudgil KD, et al. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats. J Ethnopharmacol. 2005;101:104-9. (Pubitemid 41265608)
20. Cai X, Zhou H, Wong YF, Xie Y, Liu ZQ, Jiang ZH, et al. Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula. J Ethnopharmacol. 2007;110:39-48. (Pubitemid 46209567)
21. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982; 47:412-26. (Pubitemid 13229679)
22. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84. (Pubitemid 44566469)
23. Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R, et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet. 1989; i:289-93. (Pubitemid 19049402)
24. Cadenas E. Basic mechanisms of antioxidant activity. BioFactors. 1997;6:391-7. (Pubitemid 27475624)
25. Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis. 1994;53:51-3. (Pubitemid 24067409)
26. Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem. 1997;30:351-5. (Pubitemid 27282343)
27. Sakurai H, Kohsaka H, Liu M, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression inflammatory arthritis. J Clin Invest. 1995;96:2357-63.
28. Wallace JL. Nitric oxide as a regulator of inflammatory processes. Mem Inst Oswaldo Cruz. 2005;100:5-9. (Pubitemid 40685432)
29. Kizilntuc A, Cogalgil S, Cerrahoglu L. Carnitine and antioxidants levels in patients with rheumatoid arthritis. Scand J Rheumatol. 1998;27:441-5. (Pubitemid 28535625)
30. Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol. 2001;21:69-73.
31. Masella R, Benedetto RD, Vari R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem. 2005;16:577-86. (Pubitemid 41338369)
32. Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct. 2004;22:53-7. (Pubitemid 38113621)
33. Los M, Dröge W, Stricker K, Baeuerle PA, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol. 1995;25:159-65.
34. Tinker AC, Wallace AV. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases? Curr Top Med Chem. 2006;6:77-92.
35. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol. 1999;277:L1057-65.
36. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med. 1998;25(8):891-7. (Pubitemid 28538554)
37. Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998;275:C1640-52.
38. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-9.
39. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440. (Pubitemid 26130190)
40. Severn PS, Fraser SG. Bilateral cataracts and glaucoma induced by long-term use of oral prednisolone bough over the internet. Lancet. 2006;368:618. (Pubitemid 44188884)
41. Biskupiak JE, Brixner DI, Howard KB, Oderda GM. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs. J Pain Palliat Care Pharmacother. 2006; 20:7-14. (Pubitemid 44289644)
42. Hinz B, Brune K. Pain and osteoarthritis: new drugs and mechanisms. Curr Opin Rheumatol. 2004;16:628-33. (Pubitemid 39128336)
43. Schuna AA, Megeff C. New drugs for the treatmentof rheumatoid arthritis. Am J Health Syst Pharm. 2000;57:225-34.
44. Meyer-Kirchrath J, Schrö r K. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. Curr Med Chem. 2000;7:1121-9.
45. Lester RS, Knowles SR, Shear NH. The risks of systemic corticosteroid use. Dermatol Clin. 1998;16:277-87.
46. Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal antiinflammatory agents. Am J Med. 1984;77:19-24. (Pubitemid 14057067)
47. Mamdani M, Juurlink DN, Lee DS, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population based cohort study. Lancet. 2004;363: 1751-6. (Pubitemid 38698377)
48. Santana-Sabagun E, Weisman MH. Nonsteroidal anti-inflammatory drugs. In: Ruddy S, Harris JED, Sledge CB, Budd RC, Sergent JS, editors. Kelly's textbook of rheumatology, vol. 1. Philadelphia: Saunders; 2001. p. 799-822.
49. Newman NM, Ling RSM. Acetabular bone destruction related to non-steroidal anti-inflammatory drugs. Lancet. 1985;2:11-4.
50. Anastassiades T, Chopra R, Law C, Wong E. In vitro suppression of transforming growth factor-b induced stimulation of glycosaminoglycan synthesis by acetylsalicylic acid and its reversal by misoprostol. J Rheumatol. 1998;25:1962-7. (Pubitemid 28459311)
51. Satoh Y, Powers C, Toledo LM, Kowalski TJ, Peters PA, et al. Derivatives of 2-N-(aminocarbonyl)-N-hydroxyaminomethyl- 1,4-benzodioxan as orally active 5-lipoxygenase inhibitors. J Med Chem. 1995;38:68-75.
52. Manghisi E, Salimbeni A. United States Patents. 1976; Patent number 3969368.
53. Avakyan AS, Vartanyan SO, Markaryan EA. Biologically active 2-substituted 1,4-benzodioxanes (review). Pharm Chem J. 1988; 22:600-11.
54. Labanauskas LK, Brukshtus AB, Gaidelis PG, Udrenaite EB, Daukshas VK. Synthesis and antiinflammatory activity of some new derivatives of 6-benzoyl-1,4-benzodioxane. Pharm Chem J. 1999;33:259-60.
55. Marrs TC, Bright JE, Swanston DW. Acute oral toxicity of 4-dimethylaminophenol to the gastrointestinal tract, liver and kidney of the rat. Arch Toxicol. 1982;50:89-92. (Pubitemid 12125018)
56. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109-10. (Pubitemid 13058546)
57. Bakharevski O, Stein-Oakley AN, Thomson NM, Ryan PFJ. Collagen-induced arthritis in rats: contrasting effect of subcutaneous versus intradermal inoculation of type II collagen. J Rheumatol. 1998;25:1945-52. (Pubitemid 28459308)
58. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77-88.
59. Brachertz D, Mitchell GF, MacKay IR. Antigen-induced arthritis in mice: induction of arthritis in various strains of mice. Arthritis Rheum. 1977;20:841-50.
60. Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Efficacy of sustained levels of interleukin-1 receptor antagonist in animal models of arthritis. Arthritis Rheum. 1999; 43:498-506.
61. Glenn EM, Gray J. Adjuvant-induced polyarthritis in rats: biologic and histologic background. Am J Vet Res. 1965;26:1180-94.
62. Pearson CM, Wood FD. Studies of arthritis and other lesions induced in rats by the injection of Mycobacterial adjuvant: pathologic details of the arthritis and spondylitis. Am J Pathol. 1963;42:73-95.
63. Sluka KA, Willis WD, Westlund KN. The role of dorsal root reflexes in neurogenic inflammation. Pain Forum. 1995;4:141-9.
64. Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res. 1998;23:329-40. (Pubitemid 28109878)
65. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA. 1999;96:7680-6. (Pubitemid 29328340)
66. McHugh JM, McHugh WB. Pain: neuroanatomy, chemical mediators, and clinical implications. AACN Clin Issues. 2000;11: 168-78.
67. Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol. 2001;429:115-9. (Pubitemid 33043987)
68. Ma W, Eisenach JC. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 2002;937:94-9. (Pubitemid 34521770)
69. Goodis HE, Bowles WR, Hargreaves KM. Prostaglandin E2 enhances bradykinin-evoked iCGRP release in bovine dental pulp. J Dent Res. 2000;79:1604-7.
70. Almeida IC, Camargo MM, Procopio DO, Silva LS, Mehlert A, Travassos LR, et al. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 2000;19:1476-85. (Pubitemid 30182155)
71. Lane NE, Thompson JM. Management of osteoarthritis in the primary-care setting: an evidence based approach to treatment. Am J Med. 1997;103:25S-30S. (Pubitemid 28073157)
72. Bighetti EJ, Hiruma-Lima CA, Gracioso JS, Arm SB. Antiinflammatory and antinociceptive effect in redents of the essential oil of Croton Cajucara Benth. J Pharm Pharmacol. 1999;51: 1447-53. (Pubitemid 30064077)
73. Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther. 1999;288:1288-97. (Pubitemid 29254170)
74. Gupta PK, Varshney RK, Sharma PC, Ramesh B. Molecular markers and their applications in wheat breeding. Plant Breed. 1999;118:369-90.
75. Parnham MJ. Benefits and risks of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulant therapy. In: Wagner H, editor. Immunomodulatory Agents from Plants. Birkhauser, Boston 1999; 119-135.
76. Martinez A, Anllo-Vento L, Sereno MI, Frank LR, Buxton RB, Dubowitz DJ, et al. Involvement of striate and extrastriate visual cortical areas in spatial attention. Nat Neurosci. 1999;2:364-9. (Pubitemid 30491280)
77. Wong YF, Zhou H, Wang JR, Xie Y, Xu HX, Liu L. Antiinflammatory and analgesic effects and molecular mechanisms of JCICM-6, a purified extract derived from an anti-arthritic Chinese herbal formula. Phytomed. 2008;15:416-26.
78. Bauerova K, Bezek A. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys. 1999;18:15-20. (Pubitemid 129705162)
79. Feldmann M, Brennan FM, Foxwell BM, Maini RN. The role of TNF-alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun. 2001;3:188-99.
80. Knight JA. Free radicals, antioxidants, and the immune system. Ann Clin Lab Sci. 2000;30:145-58. (Pubitemid 30238554)
81. Borel JP, Monboisse JC. Effect of oxygen free radicals on collagen in inflammation. Ann Biol Clin. 1986;44:260-5.
82. Monboisse JC, Poulin G, Braquet P, Randoux A, Ferradini C, Borel JP. Effect of oxy radicals on several types of collagen. Int J Tissue React. 1984;6:385-90. (Pubitemid 15125855)
83. Monboisse JC, Gardes-Albert M, Randoux A, Borel JP, Ferradini C. Collagen degradation by superoxide anion in pulse and gamma radiolysis. Biochim Biophys Acta. 1988;965:29-35. (Pubitemid 18099347)
84. Iyama S, Okamoto T, Sato T, Yamauchi N, Sato Y, Sasaki K, et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum. 2001;44:2160-7. (Pubitemid 33644061)
85. Salvemini D, Ischiropoulos H, Cuzzocrea S. Roles of nitric oxide and superoxide in inflammation. Methods Mol Biol. 2003;225: 291-303.
86. Fahim AT, Abd-El Fattah AA, Agha AM, Gad MZ. Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant-arthritis in rats. Pharmacol Res. 1995; 31(1): 73-9.
87. McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974;185: 529-31.
88. Greenwald RA, Moy WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980;23:455-63. (Pubitemid 10149454)